We have previously demonstrated that, in PDA patients, CT induces an antitumoral immune response, both in terms of antibody production and effector T lymphocyte response against four overexpressed PDA-associated TAA, namely ENO1, FUBP1, K2C8 and GAPDH (17). The gene discussed is FUBP1; the disease is Patent ductus arteriosus.